Both in Pharmaceuticals
Zentalis Pharmaceuticals vs Atrium Therapeutics
Over the past year ZNTL returned +33.3% and RNA returned −87.6%; their daily moves had a correlation of 0.04.
ZNTL +33.3% RNA −87.6%Growth of $1, one year, split-adjusted
| Metric | ZNTL | RNA |
|---|---|---|
| Price | $1.76 | $8.68 |
| Market cap | $166.6M | $148.5M |
| Today | −1.12% | −0.46% |
| 1 month | −34.1% | +8.6% |
| 6 months | −57.9% | −33.7% |
| Year to date | +30.4% | −88.0% |
| 1 year | +22.2% | — |
| Revenue growth (YoY) | — | −21.9% |
| Gross margin | — | 100.0% |
| Net margin | — | −672.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 4.1× |
| Net cash | $174.6M | $263.9M |
| Dividend yield | — | — |
| Volatility (60d) | 71.0% | 65.8% |
| Short % of float | 9.1% | 22.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).